DE602007012443D1 - Zyklische angiotensinanaloga - Google Patents

Zyklische angiotensinanaloga

Info

Publication number
DE602007012443D1
DE602007012443D1 DE602007012443T DE602007012443T DE602007012443D1 DE 602007012443 D1 DE602007012443 D1 DE 602007012443D1 DE 602007012443 T DE602007012443 T DE 602007012443T DE 602007012443 T DE602007012443 T DE 602007012443T DE 602007012443 D1 DE602007012443 D1 DE 602007012443D1
Authority
DE
Germany
Prior art keywords
analogs
agonistic
ang
cyclised
antagonistic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007012443T
Other languages
English (en)
Inventor
Marijke Haas
Leonardus Dorothea Kluskens
Anneke Kuipers
Rick Rink
Sieger Adriaan Nelemans
Gert Nikolaas Moll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Nanosystems BV
Original Assignee
Applied Nanosystems BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems BV filed Critical Applied Nanosystems BV
Publication of DE602007012443D1 publication Critical patent/DE602007012443D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602007012443T 2006-08-08 2007-08-07 Zyklische angiotensinanaloga Active DE602007012443D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2006/000414 WO2008130217A1 (en) 2006-08-08 2006-08-08 Cyclic angiotensin analogs
PCT/NL2007/050396 WO2008018792A2 (en) 2006-08-08 2007-08-07 Cyclic angiotensin analogs

Publications (1)

Publication Number Publication Date
DE602007012443D1 true DE602007012443D1 (de) 2011-03-24

Family

ID=37809189

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007012443T Active DE602007012443D1 (de) 2006-08-08 2007-08-07 Zyklische angiotensinanaloga

Country Status (10)

Country Link
US (1) US8835375B2 (de)
EP (1) EP2057184B1 (de)
CN (1) CN101573373B (de)
AT (1) ATE497969T1 (de)
AU (1) AU2007282221B2 (de)
CA (1) CA2660208C (de)
DE (1) DE602007012443D1 (de)
DK (1) DK2057184T3 (de)
NZ (1) NZ574876A (de)
WO (2) WO2008130217A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2163259B1 (de) * 2008-09-12 2012-06-13 Charité-Universitätsmedizin Berlin (Charité) Verwendung eines Ang-(1-7)-Rezeptorantagonisten bei akuter Lungenverletzung
JP5647146B2 (ja) 2008-12-29 2014-12-24 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． β−アレスチンエフェクターおよび組成物およびその使用方法
EP2267003A1 (de) 2009-06-24 2010-12-29 Applied NanoSystems B.V. Biologisch hergestellte cyclische Affinitätsmarker
EP2455388A1 (de) 2010-11-23 2012-05-23 LanthioPep B.V. Neuartige Rezeptoragonisten von Angiotensin des Typs 2 (AT2) und Verwendungen dafür
EP2578599A1 (de) * 2011-10-07 2013-04-10 LanthioPep B.V. Cyclische Analoga von GLP-1 und GLP-1-verwandten Peptiden
JP6225121B2 (ja) 2012-01-31 2017-11-01 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． β−アレスチンエフェクターおよび組成物ならびにそれらの使用方法
US20130210726A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease
WO2013130775A1 (en) 2012-03-01 2013-09-06 Dizerega, Gere, S. Methods for treating patients undergoing multi-cycle chemotherapy
WO2013154983A1 (en) 2012-04-09 2013-10-17 Rodgers Kathleen E Molecular markers of endothelial dysfunction in gestational diabetes
EP2849773A1 (de) 2012-05-14 2015-03-25 University of Southern California Verfahren zur begrenzung der entwicklung einer hautwunde
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
WO2014021942A1 (en) 2012-08-01 2014-02-06 University Of Southern California Methods for limiting development of neurodegeneration
CN104853749A (zh) * 2012-09-17 2015-08-19 塔瑞克斯制药有限公司 血管紧张素的口服制剂
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
EP2968441A1 (de) 2013-03-15 2016-01-20 University of Southern California Verfahren zur behandlung von multipler sklerose
AU2014233185B2 (en) 2013-03-15 2018-03-15 University Of Southern California Methods, compounds, and compositions for the treatment of angiotensin-related diseases
AU2014268524A1 (en) * 2013-05-24 2015-12-03 Tarix Pharmaceuticals Ltd. Angiotensin peptides in treating Marfan Syndrome and related disorders
CN112546197A (zh) * 2013-12-18 2021-03-26 乔治华盛顿大学国会特许非营利公司 血管紧张素ii单独或以组合方式用于治疗低血压
WO2015120316A1 (en) 2014-02-07 2015-08-13 Trevena, Inc. Crystalline and amorphous forms of a beta-arrestin effector
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
CA2948858A1 (en) 2014-05-19 2015-11-26 Trevena, Inc. Synthesis of beta-arrestin effectors
WO2016014342A2 (en) * 2014-07-21 2016-01-28 Arizona Board Of Regents For The University Of Arizona Ang-(1-7) derviative oligopeptides and methods for using and producing the same
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
EP4007592A1 (de) 2019-08-02 2022-06-08 LanthioPep B.V. Rezeptoragonisten von angiotensin typ 2 (at2) zur behandlung von krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028168A (en) * 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
SE9700301D0 (sv) * 1997-01-31 1997-01-31 Astra Ab New compound
CA2339330A1 (en) * 1998-08-13 2000-02-24 University Of Southern California Methods to increase blood flow to ischemic tissue
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way

Also Published As

Publication number Publication date
US8835375B2 (en) 2014-09-16
CN101573373B (zh) 2014-04-30
EP2057184A2 (de) 2009-05-13
AU2007282221A1 (en) 2008-02-14
US20100055146A1 (en) 2010-03-04
WO2008018792A2 (en) 2008-02-14
EP2057184B1 (de) 2011-02-09
NZ574876A (en) 2011-03-31
AU2007282221B2 (en) 2010-09-02
CA2660208C (en) 2012-05-22
DK2057184T3 (da) 2011-05-02
CA2660208A1 (en) 2008-02-14
ATE497969T1 (de) 2011-02-15
CN101573373A (zh) 2009-11-04
WO2008130217A1 (en) 2008-10-30
WO2008018792A3 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
DE602007012443D1 (de) Zyklische angiotensinanaloga
WO2008075371A3 (en) T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
GT200900304A (es) "antagonistas ciclicos de peptido cxcr4"
WO2006097536A3 (en) Dimeric peptide agonists of the glp-1 receptor
SI2190473T1 (sl) Peptid z zmanjšano tvorbo dimerov
UA94221C2 (en) Lipocalin protein
BR112012011332A2 (pt) agentes direcionados para gadd45beta
EP1751179A4 (de) Von kasein abgeleitete peptide und therapeutischer gebrauch davon
DE602005008996D1 (de) Radiofluorierte peptide
DE602005023247D1 (de) Bipolares elektrochirurgisches Instrument mit Gelenk
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
CL2007002327A1 (es) Compuestos derivados de fenil-imidazol sustituido; composicion farmaceutica; y uso en el tratamiento del vhc.
IL192373A (en) Arginine cyclic peptides and their use in the treatment of fungal infections
NZ607892A (en) Tfpi inhibitors and methods of use
EA201000329A1 (ru) Циклические депсипептиды
EP2402364A3 (de) Nonapeptide mit Antitumoraktivität
IL175063A0 (en) Pif peptides biologic activities, site of action, and the antibody to detect pif
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof
DE602006019556D1 (de) Antiblockzusammensetzungen mit interpolymeren von ethylen/alpha-olefinen
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
FR2949782B1 (fr) Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.
EA200800205A1 (ru) Кальций-пептидный компонент
DE502007002251D1 (de) Oligopeptide enthaltende dermatologische Zusammensetzungen zur Steigerung der Hautempfindlichkeit
WO2006064530A3 (en) Dermorphin analogs with analgesic activity

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 2057184

Country of ref document: EP

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE